Caroline B. Moore
Manchester, ENG M239LT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Comparison of β-1-3-D-Glucan and Candida Mannan Biomarker Assays with Serological Tests for the Diagnosis of Candidemia.
Journal: Journal of fungi (Basel, Switzerland)
Published: June 05, 2023
COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses.
Journal: Microbiology spectrum
Published: March 22, 2023
Absence of Azole Antifungal Resistance in Aspergillus fumigatus Isolated from Root Vegetables Harvested from UK Arable and Horticultural Soils.
Journal: Journal of fungi (Basel, Switzerland)
Published: September 18, 2020
Isavuconazole Therapeutic Drug Monitoring during Long-Term Treatment for Chronic Pulmonary Aspergillosis.
Journal: Antimicrobial agents and chemotherapy
Published: July 15, 2020
Talaromycosis in a renal transplant recipient returning from South China.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: May 30, 2020
Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
Journal: The Journal of antimicrobial chemotherapy
Published: May 24, 2020
Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
Journal: Mycoses
Published: December 09, 2019
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 27, 2019
Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species.
Journal: Future microbiology
Published: November 13, 2018
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
Journal: The Journal of antimicrobial chemotherapy
Published: August 21, 2018
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Journal: Mycoses
Published: August 19, 2018
Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital.
Journal: The Journal of antimicrobial chemotherapy
Published: April 24, 2018
Last Updated: 09/26/2026